Trial intelligence / Profile preview

Clobetasol Propionate Shampoo in Scalp Seborrheic Dermatitis

NCT00862654Phase 3Completed

Sponsor
Galderma
Start
Mar 2009
Primary completion
Feb 2010
Modality
Small Molecules
Countries
5
01

Overview

Phase 3, randomised trial of clobetasol in seborrheic dermatitis (SD) (4 arms), sponsored by Galderma. Primary endpoint: Total Severity Score at 4 weeks. Started Mar 2009; status: completed.

02

Drugs

clobetasol
03

Conditions

seborrheic dermatitis (SD)

Beyond the preview

Go deeper on NCT00862654.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00862654.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call